The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
COVID-19-Related Stroke
Open accessAbstract
The COVID-19 pandemic is associated with neurological symptoms and complications including stroke. There is hypercoagulability associated with COVID-19 that is likely a “sepsis-induced coagulopathy” and may predispose to stroke. The SARS-CoV-2 virus binds to angiotensin-converting enzyme 2 (ACE2) present on brain endothelial and smooth muscle cells. ACE2 is a key part of the renin angiotensin system (RAS) and a counterbalance to angiotensin-converting enzyme 1 (ACE1) and angiotensin II. Angiotensin II is proinflammatory, is vasoconstrictive, and promotes organ damage. Depletion of ACE2 by SARS-CoV-2 may tip the balance in favor of the “harmful” ACE1/angiotensin II axis and promote tissue injury including stroke. There is a rationale to continue to treat with tissue plasminogen activator for COVID-19-related stroke and low molecular weight heparinoids may reduce thrombosis and mortality in sepsis-induced coagulopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Tang, N., Bai, H., Chen, X., Gong, J., Li, D., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14817 · Cited by 3,559
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179
Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122 · cited 1×
“For a more “targeted” COVID-19 therapy, one promising treatment is to supply exogenous ACE2 by administering human recombinant soluble ACE2 (hrsACE2) which inhibited SARS-CoV-2 infections in engineered human blood vessel organoids [24].”
BackgroundNetland, J., Meyerholz, D. K., Moore, S., Cassell, M., & Perlman, S. (2008) · Journal of Virology · doi:10.1128/jvi.00737-08 · Cited by 1,293
Mao, L., Wang, M., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., Li, Y., Jin, H., et al. (2020) · medRxiv · doi:10.1101/2020.02.22.20026500 · Cited by 875
Khan, A., Benthin, C., Zeno, B., Albertson, T. E., Boyd, J., Christie, J. D., Hall, R., Poirier, G., Ronco, J. J., Tidswell, M., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1823-x · Cited by 602
Wang, J., Hajizadeh, N., Moore, E. E., McIntyre, R. C., Moore, P. K., Veress, L. A., Yaffe, M. B., Moore, H. B., & Barrett, C. D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14828 · Cited by 536
Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation
Iba, T., Levy, J. H., Warkentin, T. E., Thachil, J., van der Poll, T., & Levi, M. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14578 · Cited by 531
Age- and gender-related difference of ACE2 expression in rat lung
Xudong, X., Junzhu, C., Xingxiang, W., Furong, Z., & Yanrong, L. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.09.038 · Cited by 410 · cited 1×
“ACE2 in the lung declines with age and the decrease in males with age is greater than that in females [21].”
BackgroundDoobay, M. F., Talman, L. S., Obr, T. D., Tian, X., Davisson, R. L., & Lazartigues, E. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00292.2006 · Cited by 406
Arendse, L. B., Danser, A. H. J., Poglitsch, M., Touyz, R. M., Burnett, J. C., Llorens-Cortes, C., Ehlers, M. R., & Sturrock, E. D. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017129 · Cited by 339
ACE2/ANG-(1–7)/Mas pathway in the brain: the axis of good
Xu, P., Sriramula, S., & Lazartigues, E. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00222.2010 · Cited by 283
Kuhn, J. H., Li, W., Choe, H., & Farzan, M. (2004) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-004-4242-5 · Cited by 249
Paleolithic to Bronze Age Siberians Reveal Connections with First Americans and across Eurasia
Yu, H., Spyrou, M. A., Karapetian, M., Shnaider, S., Radzevičiūtė, R., Nägele, K., Neumann, G. U., Penske, S., Zech, J., Lucas, M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.037 · Cited by 216
Mecca, A. P., Regenhardt, R. W., O’Connor, T. E., Joseph, J. P., Raizada, M. K., Katovich, M. J., & Sumners, C. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2011.058578 · Cited by 197
Antiphospholipid antibodies, antiphospholipid syndrome and infections
Sène, D., Piette, J.-C., & Cacoub, P. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2007.10.001 · Cited by 190
Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke
Regenhardt, R. W., Desland, F. A., Mecca, A. P., Pioquinto, D. J., Afzal, A., Mocco, J., & Sumners, C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.025 · Cited by 148
Systematic review of case reports of antiphospholipid syndrome following infection
Abdel‐Wahab, N., Lopez-Olivo, M. A., Pinto-Patarroyo, G. P., & Suarez-Almazor, M. E. (2016) · Lupus · doi:10.1177/0961203316640912 · Cited by 140
Chen, J., Xiao, X., Chen, S., Zhang, C., Chen, J., Yi, D., Shenoy, V., Raizada, M. K., Zhao, B., & Chen, Y. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.00202 · Cited by 102
Neuronal over-expression of ACE2 protects brain from ischemia-induced damage
Chen, J., Zhao, Y., Chen, S., Wang, J., Xiao, X., Ma, X., Penchikala, M., Xia, H., Lazartigues, E. D., Zhao, B., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.004 · Cited by 96
Regenhardt, R. W., Mecca, A. P., Desland, F. A., Ritucci‐Chinni, P. F., Ludin, J. A., Greenstein, D., Bañuelos, C., Bizon, J. L., Reinhard, M. K., & Sumners, C. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2013.075242 · Cited by 67
And Sepsis Study Group, von Seth, M., Hillered, L., Otterbeck, A., Hanslin, K., Larsson, A., Sjölin, J., Lipcsey, M., Cove, M., Chew, N. S., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1629-x · Cited by 49
Proinflammation of Aging Central Arteries: A Mini-Review
Wang, M., Monticone, R. E., & Lakatta, E. G. (2014) · Gerontology · doi:10.1159/000362548 · Cited by 42
Cited by
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Wang, M.-Y., Zhao, R., Gao, L.-J., Gao, X.-F., Wang, D.-P., & Cao, J.-M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.587269 · Cited by 874
Stroke in COVID-19: A systematic review and meta-analysis
Nannoni, S., de Groot, R., Bell, S., & Markus, H. S. (2021) · International Journal of Stroke · doi:10.1177/1747493020972922 · Cited by 584
Goldman, I. A., Ye, K., & Scheinfeld, M. H. (2020) · Radiology · doi:10.1148/radiol.2020202348 · Cited by 366
Hernández-Fernández, F., Sandoval Valencia, H., Barbella-Aponte, R. A., Collado-Jiménez, R., Ayo-Martín, Ó., Barrena, C., Molina-Nuevo, J. D., García-García, J., Lozano-Setién, E., Alcahut-Rodriguez, C., et al. (2020) · Brain · doi:10.1093/brain/awaa239 · Cited by 280
Najjar, S., Najjar, A., Chong, D. J., Pramanik, B. K., Kirsch, C., Kuzniecky, R. I., Pacia, S. V., & Azhar, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01896-0 · Cited by 282
Metadata
- Authors
- Hess, D. C., Eldahshan, W., & Rutkowski, E.
- Venue
- Translational Stroke Research
- Published
- 2020-05-07
- Volume
- 11
- Issue
- 3
- Pages
- 322-325
- ISSN
- 1868-4483 (ISSN-L)
- 1868-601X
- OpenAlex
- W3022960164
- Cited by
- 381
- References
- 27
- FWCI
- 10.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.